FDA approval of Biogen's Alzheimer's drug sparked debate over its cost and efficacy. CP3 Director Dr. Walid Gellad spoke with Meg Tirrell on CNBC's The News with Shepard Smith about the drug. Watch the clip here.
FDA approval of Biogen's Alzheimer's drug sparked debate over its cost and efficacy. CP3 Director Dr. Walid Gellad spoke with Meg Tirrell on CNBC's The News with Shepard Smith about the drug. Watch the clip here.